首页> 外文期刊>Orthopaedic Journal of Sports Medicine >OSTEOCHONDRAL ALLOGRAFTING IN THE SKELETALLY IMMATURE KNEE: HIGH RATES OF INCORPORATION AND EXCELLENT EARLY OUTCOMES
【24h】

OSTEOCHONDRAL ALLOGRAFTING IN THE SKELETALLY IMMATURE KNEE: HIGH RATES OF INCORPORATION AND EXCELLENT EARLY OUTCOMES

机译:骨质色神经聚糖在骨架不成熟的膝盖中:<粗体>融合高速和出色的早期结果

获取原文
获取外文期刊封面目录资料

摘要

Background: While an excellent option for osteochondral defects in the adult knee, outcomes following fresh osteochondral allograft (OCA) the skeletally immature are limited. Purpose: To compare radiographic and patient reported outcomes (PROs) in mature and skeletally immature adolescents following OCA of the knee. Methods: An IRB-approved review of fresh size-matched OCA treatment of knee lesions in patients aged & 19 years within a pediatric sports medicine practice from 1/2006-3/2019 was completed. Following exclusion of patients with less than 12 months follow-up, demographics, lesion characteristics, reoperations, and PROs were evaluated. A novel grading scale (k= 0.832) was utilized to evaluate radiographic OCA incorporation: A=complete, B= &50%, or C= &50% healed. Results: Forty-four patients [15.5 years (9.6-19.8) treated with OCA of the distal femur or patella (LFC= 18, MFC=17, Trochlea=6, Patella=3), 24 with open and 20 with closed physes, with 2.2 year follow up (range 1-5.3 years) were evaluated. Overall average graft size was 4.76cm2 and did not differ significantly between groups. Thirty-nine patients underwent at least one prior procedure to the ipsilateral knee, most frequently for attempted osteochondral lesion healing (77%), followed by realignment (22.7%), and meniscal pathology (15.9%). Graft failure occurred in only one skeletally immature patient with a trochlear lesion. Those with open physes were more likely to demonstrate complete graft incorporation (66.6%, p=0.001). 21(88%) patients with open physes and 17(85%) patients with closed physes had radiographic healing grades of A or B one year post-operatively. There was no difference in healing grade based on graft size, depth, or location within the knee. There was no difference in pre-operative PROs or activity scores. At final follow-up, open physes OCA patients demonstrated better KOOS scores (KOOS daily living 97.0 vs 89.5, p=0.02; KOOS pain 95.7 vs 84.6, p= 0.04; KOOS quality of life 157.2 vs 59.6, p= 0.005). Final activity scores did not vary by skeletal maturity (Pedi-IKDC 75.8 vs 77.99; Pedi-FABS 17.2 vs 13.5,) or radiographic healing grade. Daily living and pain scores were better in those with more radiographic healing (KOOS daily living 98.6 vs 86,2, p= 0.02; KOOS pain 96.7 vs 82.3, p= 0.048). Conclusion: Fresh osteochondral allograft treatment in the young knee may be expected to yield good early results. Despite relatively large graft size, when indicated for patients with open physes, equivalent or improved healing and patient reported outcomes may be expected.
机译:背景:虽然成人膝关节内骨质缺损的出色选择,但新鲜骨质色神经移植后的结果(OCA)骨架不成熟是有限的。目的:将射线照相和患者报告的成熟和骨骼未成熟的青少年中报告的结果(优点)进行比较。方法:IRB批准审查患者膝关节病变的新鲜尺寸匹配的OCA治疗&amp; 19年内在儿科体育中,从1/2006 - 3/3 / 2019年完成。除了排除患者不到12个月后续后续的患者,评估人口统计,病变特征,重新进展和专业权。利用新的分级秤(K = 0.832)来评估射线照相OCA掺入:a =完全,b =&amp; 50%,或c =&amp; 50%愈合。结果:四十四名患者[15.5岁(9.6-19.8)治疗远端股骨或髌骨(LFC = 18,MFC = 17,Trochlea = 6,Trochlea = 6,髌骨= 3),24个,带封闭物理的20个,评估了2.2年的后续(范围1-5.3岁)。总平均接枝尺寸为4.76cm2,在组之间没有显着差异。三十九名患者在同侧膝关节中至少进行了一个先前的程序,最常用于骨质色神经病变愈合(77%),其次重新调整(22.7%)和半月板病理(15.9%)。移植物失败仅发生在具有Trochlear病变的一个骨架未成熟的患者中。具有开放物理的人更有可能展示完整的移植物掺入(66.6%,P = 0.001)。 21(88%)患有开放物理的患者和17例(85%)患者封闭物理患者术后一年的射线照相愈合等级。基于膝盖内的移植尺寸,深度或位置,治疗级别没有差异。术前的专业人士或活动分数没有差异。在最终的后续后,开放物理OCA患者展示了更好的KOOS分数(KOOS日常生活97.0 VS 89.5,P = 0.02; KOOS疼痛95.7 VS 84.6,P = 0.04; KOOS生命质量157.2 VS 59.6,P = 0.005)。最终的活动分数没有因骨骼成熟度而变化(Pedi-IKDC 75.8 VS 77.99; Pedi-Fab,17.2 Vs 13.5,)或射线照相愈合等级。在那些具有更多射线照相愈合的人中日常生活和疼痛评分(KOOS日常生活98.6 VS 86,2,P = 0.02; KOOS疼痛96.7 VS 82.3,P = 0.048)。结论:幼膝的新鲜骨质色神经移植治疗可能有望产生良好的早期效果。尽管移植物尺寸相对较大,但是当针对开放物理学的患者指出时,可以预期等效或改善的愈合和患者报告的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号